Bioxytran Inc

Company Profile

Bioxytran Inc had its IPO on under the ticker symbol BIXT.

The company operates in the Healthcare sector and Biotechnology industry. Bioxytran Inc has a staff strength of 2 employees.

Stock update

Shares of Bioxytran Inc opened at $0.17 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.14 - $0.17, and closed at $0.16.

This is a -5.88% slip from the previous day's closing price.

A total volume of 211,843 shares were traded at the close of the day’s session.

In the last one week, shares of Bioxytran Inc have slipped by -29.67%.

Bioxytran Inc's Key Ratios

Bioxytran Inc has a market cap of $39.57 million, indicating a price to book ratio of 0 and a price to sales ratio of 532.5585.

In the last 12-months Bioxytran Inc’s revenue was $0 with a gross profit of $0 and an EBITDA of $-2065248. The EBITDA ratio measures Bioxytran Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bioxytran Inc’s operating margin was 0% while its return on assets stood at -248.27% with a return of equity of 0%.

In Q1, Bioxytran Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Bioxytran Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.02 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bioxytran Inc’s profitability.

Bioxytran Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -25.581. Its price to sales ratio in the trailing 12-months stood at 532.5585.

Bioxytran Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$233533.00

Total Liabilities

$4.29 million

Operating Cash Flow

$-4711.00

Capital Expenditure

$4711

Dividend Payout Ratio

0%

Bioxytran Inc ended 2024 with $233533.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $233533.00 while shareholder equity stood at $-3437001.00.

Bioxytran Inc ended 2024 with $0 in deferred long-term liabilities, $4.29 million in other current liabilities, 123502.00 in common stock, $-12002683.00 in retained earnings and $0 in goodwill. Its cash balance stood at $153801.00 and cash and short-term investments were $153801.00. The company’s total short-term debt was $2,165,000 while long-term debt stood at $0.

Bioxytran Inc’s total current assets stands at $153801.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $1.10 million and inventory worth $0.

In 2024, Bioxytran Inc's operating cash flow was $-4711.00 while its capital expenditure stood at $4711.

Comparatively, Bioxytran Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.16

52-Week High

$1.25

52-Week Low

$0.15

Analyst Target Price

$

Bioxytran Inc stock is currently trading at $0.16 per share. It touched a 52-week high of $1.25 and a 52-week low of $1.25. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0.17 and 200-day moving average was $0.35 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6737.9% of the company’s stock are held by insiders while 0% are held by institutions.